OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2 ‐negative metastatic breast cancer
Hyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 4, pp. 917-924
Open Access | Times Cited: 8
Hyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 4, pp. 917-924
Open Access | Times Cited: 8
Showing 8 citing articles:
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Konstantinos Venetis, Roberto Piciotti, Elham Sajjadi, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1377-1377
Open Access | Times Cited: 60
Konstantinos Venetis, Roberto Piciotti, Elham Sajjadi, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1377-1377
Open Access | Times Cited: 60
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis
Hanieh Kolahi Azar, Maliheh Gharibshahian, Mohammadreza Rostami, et al.
Journal of Biological Engineering (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Hanieh Kolahi Azar, Maliheh Gharibshahian, Mohammadreza Rostami, et al.
Journal of Biological Engineering (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy
Feifan Xiang, Huipan Liu, Jia Deng, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5758-5758
Open Access | Times Cited: 14
Feifan Xiang, Huipan Liu, Jia Deng, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5758-5758
Open Access | Times Cited: 14
A global bibliometric and visualized analysis of the status and trends of bone metastasis in breast cancer research from 2002 to 2021
Li Li, Nengbin Wan, Ying He, et al.
Journal of bone oncology (2023) Vol. 42, pp. 100500-100500
Open Access | Times Cited: 5
Li Li, Nengbin Wan, Ying He, et al.
Journal of bone oncology (2023) Vol. 42, pp. 100500-100500
Open Access | Times Cited: 5
CDK4/6 inhibitors versus PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated systematic review and network meta-analysis of 28 randomized controlled trials
Hangcheng Xu, Yan Wang, Yiqun Han, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Hangcheng Xu, Yan Wang, Yiqun Han, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors
Liang Xu, Junli Xue, Xiaoxiao Ge, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Liang Xu, Junli Xue, Xiaoxiao Ge, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
The role of everolimus in metastatic breast cancer and possibilities of moving forward—a narrative review
Gábor Rubovszky
Annals of Translational Medicine (2024) Vol. 12, Iss. 4, pp. 68-68
Open Access
Gábor Rubovszky
Annals of Translational Medicine (2024) Vol. 12, Iss. 4, pp. 68-68
Open Access
Beyond resorption: osteoclasts as drivers of bone formation
Qianfeng Xiang, Lie Li, Wei Ji, et al.
Cell Regeneration (2024) Vol. 13, Iss. 1
Open Access
Qianfeng Xiang, Lie Li, Wei Ji, et al.
Cell Regeneration (2024) Vol. 13, Iss. 1
Open Access
